Me-PB-Hyos Tablets and Pexidartinib Hydrochloride
Determining the interaction of Me-PB-Hyos Tablets and Pexidartinib Hydrochloride and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: Coadministration of pexidartinib with strong CYP450 3A4 inducers may decrease the plasma concentrations and therapeutic effects of pexidartinib. The proposed mechanism is induction of CYP450 3A4, the isoenzyme responsible for the metabolic clearance of pexidartinib. Concomitant administration of rifampin, a strong CYP450 3A4 inducer, decreased pexidartinib peak plasma concentration (Cmax) and systemic exposure (AUC) by 33% and 65%, respectively. The effect of coadministration with a moderate CYP450 3A4 inducer on pexidartinib pharmacokinetics is unknown. MANAGEMENT: The use of pexidartinib with strong CYP450 3A4 inducers is not recommended. References "Product Information. Turalio (pexidartinib)." Daiichi Sankyo, Inc., Parsippany, NJ.
Professional:GENERALLY AVOID: Coadministration of pexidartinib with strong CYP450 3A4 inducers may decrease the plasma concentrations and therapeutic effects of pexidartinib. The proposed mechanism is induction of CYP450 3A4, the isoenzyme responsible for the metabolic clearance of pexidartinib. Concomitant administration of rifampin, a strong CYP450 3A4 inducer, decreased pexidartinib peak plasma concentration (Cmax) and systemic exposure (AUC) by 33% and 65%, respectively. The effect of coadministration with a moderate CYP450 3A4 inducer on pexidartinib pharmacokinetics is unknown.
MANAGEMENT: The use of pexidartinib with strong CYP450 3A4 inducers is not recommended.
- "Product Information. Turalio (pexidartinib)." Daiichi Sankyo, Inc., Parsippany, NJ.
Generic Name: atropine / hyoscyamine / phenobarbital / scopolamine
Brand name: Donnatal, D-Tal, Phenohytro, Chardonna-2, Hyosophen, Donnapine, Elixiral, Bellatal, Spasmolin, Haponal, Antispas, Barbidonna, Donnatal Extentabs, Antispasmodic, Bellalphen, Donnaphen, Spasquid, Alkabel-SR, Bellatal ER, Servira, PB-Hyos, Quadrapax, Phenobarbital with Belladonna Alkaloids
Synonyms: Me-PB-Hyos Elixir
Generic Name: pexidartinib
Brand name: Turalio
Synonyms: Pexidartinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Me-PB-Hyos Tablets-Pfizerpen
- Me-PB-Hyos Tablets-Pharaon Tea
- Me-PB-Hyos Tablets-Pharmorubicin Pfs
- Me-PB-Hyos Tablets-Phazyme
- Me-PB-Hyos Tablets-Phazyme Liquid Gas Relief, Maximum Strength
- Me-PB-Hyos Tablets-Phena-Plus
- Pexidartinib Hydrochloride-ME/NaPhos/MB/Hyo1
- Pexidartinib Hydrochloride-Measles and rubella virus vaccine live Intramuscular, Injection
- Pexidartinib Hydrochloride-Measles virus vaccine, live Subcutaneous
- Pexidartinib Hydrochloride-Measles, mumps, and rubella (MMR) vaccine
- Pexidartinib Hydrochloride-Measles, Mumps, and Rubella Vaccine
- Pexidartinib Hydrochloride-Measles, Mumps, and Rubella Virus Vaccine